Erlotinib "Viatris" 100 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

erlotinib "viatris" 100 mg filmovertrukne tabletter

viatris limited - erlotinibhydrochlorid - filmovertrukne tabletter - 100 mg

Erlotinib "Viatris" 150 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

erlotinib "viatris" 150 mg filmovertrukne tabletter

viatris limited - erlotinibhydrochlorid - filmovertrukne tabletter - 150 mg

Erlotinib "Sandoz" 100 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

erlotinib "sandoz" 100 mg filmovertrukne tabletter

sandoz a/s - erlotinibhydrochlorid - filmovertrukne tabletter - 100 mg

Erlotinib "Sandoz" 150 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

erlotinib "sandoz" 150 mg filmovertrukne tabletter

sandoz a/s - erlotinibhydrochlorid - filmovertrukne tabletter - 150 mg

Erlotinib "Teva" 100 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

erlotinib "teva" 100 mg filmovertrukne tabletter

teva b.v. - erlotinibhydrochlorid - filmovertrukne tabletter - 100 mg

Erlotinib "Teva" 150 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

erlotinib "teva" 150 mg filmovertrukne tabletter

teva b.v. - erlotinibhydrochlorid - filmovertrukne tabletter - 150 mg

Erlotinib "Teva" 25 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

erlotinib "teva" 25 mg filmovertrukne tabletter

teva b.v. - erlotinibhydrochlorid - filmovertrukne tabletter - 25 mg

Jaypirca Den Europæiske Union - dansk - EMA (European Medicines Agency)

jaypirca

eli lilly nederland b.v. - pirtobrutinib - lymfom, mantelcelle - protein kinase hæmmere - treatment of mantle cell lymphoma (mcl).

Cabometyx Den Europæiske Union - dansk - EMA (European Medicines Agency)

cabometyx

ipsen pharma - cabozantinib (s)-malate - carcinoma, renal cell; carcinomas, hepatocellular - antineoplastiske midler - renal cell carcinoma (rcc)cabometyx is indicated as monotherapy for the treatment of advanced renal cell carcinoma (rcc):in treatment-naïve adults with intermediate or poor risk,in adults following prior vascular endothelial growth factor (vegf)-targeted therapy. cabometyx, in combination with nivolumab, is indicated for the first-line treatment of advanced renal cell carcinoma in adults. hepatocellular carcinoma (hcc)cabometyx is indicated as monotherapy for the treatment of hepatocellular carcinoma (hcc) in adults who have previously been treated with sorafenib.

Erlotinib "ratiopharm" 100 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

erlotinib "ratiopharm" 100 mg filmovertrukne tabletter

ratiopharm gmbh - erlotinibhydrochlorid - filmovertrukne tabletter - 100 mg